Laboratory of Lymphocyte Signaling and Oncoproteome

Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia

Lohmann, G Vasyutina, E Bloehdorn, J Reinart, N Schneider, J Babu, V Knittel, G Crispatzu, G Mayer, P Prinz, C‎ Biersack, B Efremov, D Chessa, L Herling, CD Stilgenbauer, S Hallek, M Schobert, R Reinhardt, HC Schumacher, B‎ Herling, M
Leukemia 31, 5May, 2017Pages: 1177-86doi: 10.1038/leu.2016.294ISSN: 1476-5551https://www.nature.com/articles/leu2016294/

Full text

News

Future therapies in T-PLL and T-LGL

Future therapies in T-PLL and T-LGL

June 7, 2021

New perspective on future targeted therapy approaches published.

New article accepted for publication

New article accepted for publication

August 30, 2020

Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood

Alkylating deacetylase inhibitor tinostamustine in T-PLL

March 11, 2020

New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.

Advances and Perspectives in the Treatment of T-PLL

Advances and Perspectives in the Treatment of T-PLL

February 25, 2020

New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports